avarice
发表于 2025-3-26 21:58:43
Emerging Neurobiology of Antidepressant Treatments
semble
发表于 2025-3-27 04:12:30
SSRIs in the Treatment of Depression: A Pharmacological CUL-DE-SAC?,ficacy, at the cost of a greater side-effect burden. Attempts to supplement serotonin reuptake activity with actions at serotonin receptor sub-types have not yet yielded substantial benefits; however, vortioxetine may provide more utility in the management of cognitive impairment. Future advances mi
忍耐
发表于 2025-3-27 07:51:28
http://reply.papertrans.cn/33/3206/320558/320558_33.png
CRANK
发表于 2025-3-27 10:55:18
Opioid Mechanisms and the Treatment of Depression,standing of the diverse mechanisms through which opioid system modulation may improve depressive symptoms could ultimately aid in the development of safe and effective alternative treatments for individuals with difficult-to-treat depression.
你正派
发表于 2025-3-27 15:39:44
http://reply.papertrans.cn/33/3206/320558/320558_35.png
核心
发表于 2025-3-27 18:09:07
http://reply.papertrans.cn/33/3206/320558/320558_36.png
恃强凌弱
发表于 2025-3-28 01:01:44
Microbiota-Gut-Brain Axis and Antidepressant Treatment,ing deficits in catecholaminergic and monoamine neurotransmission. Interestingly, there is evidence to suggest that antidepressants may play a role in modulating the gut microbiota, thereby possibly having an impact on the microbiota-gut-brain axis in this manner. The development of prebiotics, prob
折磨
发表于 2025-3-28 05:50:16
http://reply.papertrans.cn/33/3206/320558/320558_38.png
索赔
发表于 2025-3-28 09:28:38
http://reply.papertrans.cn/33/3206/320558/320558_39.png
讽刺
发表于 2025-3-28 11:06:59
http://reply.papertrans.cn/33/3206/320558/320558_40.png